1Nix P, Nicolaides A, Coatesworth AP. Thyroid cancer re- view 1: presentation and investigation of thyroid cancer [J]. Int J Clin Pract,2005,59(11):1340-1344.
2Nawrot I, Pragacz A, Pragacz K, et al. Total thyroidecto- my is associated with increased prevalence of permanent hypoparathyroidism[J]. Med Sci Monit,2014,20:1675-1681.
3Mohebati A, Shaha AR. Anatomy of thyroid and parathy-roid glands and neurovascular relations[J]. Clin Anat, 2012,25(1):19-31.
5Dudley NE. Methylene blue for rapid identification of the parathyroids[J]. Br Med J,1971,3(5776):680-681.
6Kadoya T, Kinoshita Y, Shiraishi M, et al. Seven cases of parathyroidectomy for secondary hyperparathyroidism using methylene blue: suggestion for the method of methylene blue infusion[J]. Masui,2014,63(8):862-865.
7Bewick J, Pfleiderer A. The value and role of low dose methylene blue in the surgical management of hyper- parathyroidism[J]. Ann R Coil Surg Engl,2014,96(7):526- 529.
8Shopes E, Gerard W, Baughman J. Methylene blue en- cephalopathy: a case report and review of published ca- ses[J]. AANA J,2013,81(3):215-221.
9Patel HP, Chadwick DR, Balasubramanian SP. Systematic review of intravenous methylene blue in parathyroid surgery[J]. Br J Surg,2012,99(10):1345-1351.
10Chance B. Near-infrared images using continuous, phase- modulated, and pulsed light with quantitation of blood and blood oxygenationa[J]. Ann N Y Acad Sci,1998,838: 29-45.
二级参考文献42
1Hagiwara A, staining with India ink : Lymphology, Takahashi T, Sawai K, et al. Lymph nodal vital newer carbon particle suspensions compared with experimental and clinical observations [ J ]. 1992,25 (2) : 84-89.
2Roh JL, Park JY, Park CI. Total thyroidectomy plus neck dissection in differentiated papillary thyroid carcinoma patients: pattern of nodal metastasis, morbidity, recurrence, and postoperative levels of serum parathyroid hormone [ J ]. Ann Surg, 2007,245 (4) :604-610.
3Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study[J]. Cancer, 2000,89( 1 ) :202-217.
4Cooper DS, Doherty GM, Hangen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2006,16(2) :109-142.
5Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J ]. Thyroid, 2009, 19( 11 ) : 1167-1214.
6White ML, Gauger PG, Doherty GM. Central lymph node dissection in differentiated thyroid cancer [ J ]. World J Surg, 2007,31 (5) :895-904.
7Moo TA, McGill J, Allendorf J, et al. Impact of prophylactic central neck lymph node dissection on earl.y recurrence in papillary thyroid carcinoma[J]. World J Surg, 2010, 34(6) :1187-1191.
8Sywak MS, Palazzo FF, Yeh M, et al. Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy[ J]. ANZ J Surg, 2007,77 ( 8 ) :667-670.
9Henry ,IF, Gramatica L, Denizot A, et al. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma [J]. Langenbecks Arch Surg, 1998,383 (2) : 167-169.
10Jung KW, Won Y J, Kong H J, et al. Cancer statistics in Korea: in- cidence, mortality, survival and prevalence in 2012 [J]. Cancer Res Treat, 2015, 47(2):127-141.
